Clinical End Point Studies

QPS Bioserve can also design and conduct pharmacodynamic endpoint studies to establish bioequivalence for drug products where it is not possible to establish bioequivalence by pharmacokinetic endpoints

These studies are conducted in association with clinical sites which are equipped to conduct the studies in a GCP compliant manner ensuring the integrity and reliability of the data.